CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM-Reference-Cited by-同舟云学术

CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM

Published:2017-12-30 Issue:3 Volume: Page:80-83
ISSN:2658-5790
Container-title:Medical Council
language:
Short-container-title:Medicinskij sovet

Author:

Troshina E. A.¹,Galieva M. O.¹,Mikhina M. S.¹,Mazurina N. V.¹

Affiliation:

1. Endocrinology Research Center, MoH RF

Abstract

Among comorbidities of obesity, hypothyroidism is the most common endocrinopathy. The pathogenesis of both diseases is based on serotonin deficiency. The article tells about a clinical case of a patient with obesity and subclinical hypothyroidism; a comprehensive examination allowed to choose the efficient and safe pathogenetic therapy.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference21 articles.

1. Yeo G, Heisler L. Unraveling the brain regulation of appetite: lessons from genetics. Nat Neurosci, 2012, 15(10): 1343-1349. doi: 10.1038/nn.3211.

2. Galieva MO, Troshina EA, Mazurina NV, et al. The role of genetic factors in predicting results of obesity treatment with sibutramine – serotonin-norepinephrine reuptake inhibitor. Obesity and metabolism, 2016, 13(4): 21-26. doi: 10.14341/OMET2016421-26.

3. Zamponi GW, Currie KP. Regulation of CaV 2 calcium channels by G protein coupled receptors. Biochim Biophys Acta, 2013, 1828: 1629-1643. doi: 10.1016/j.bbamem.2012.10.004.

4. Chung KY, Rasmussen SG, Liu T, Li S, DeVree BT, Chae PS et al. Conformational changes in the G protein Gs induced by the beta2 adrenergic receptor. Nature, 2011, 477: 611-615. doi: 10.1038/nature10488.

5. Lychkova A.E. Nervnaya regulyatsiya funktsii shchitovidnoi zhelezy. Vestnik RAMN. 2013, 6: 49-55.